• Current and Emerging Treatment Landscape of mHSPC

  • Feb 24 2025
  • Length: 36 mins
  • Podcast

Current and Emerging Treatment Landscape of mHSPC

  • Summary

  • Jack Andrews MD; Eugene Cone, MD; and Arash Rezazadeh, MD, discuss how metastatic hormone-sensitive prostate cancer presents clinically, explore current treatment standards including combination therapies, evaluate emerging data from the ARANOTE trial on darolutamide efficacy, consider quality of life factors in treatment selection, and examine how novel therapeutic approaches may reshape future care pathways.
    Show More Show Less

What listeners say about Current and Emerging Treatment Landscape of mHSPC

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.